Use of routine thoracentesis in addition to medical therapy yielded no significant benefits for adults with heart failure and ...

None of the eteplirsen-treated patients reached a left ventricular ejection fraction below 50% compared with 22.1% of patients in the control group.

Whether newer pacing techniques can mitigate death, LV decline, and HF symptoms in TAVI patients remains to be seen.

JARDIANCE is not recommended in patients with type 1 diabetes mellitus. It may increase their risk of diabetic ketoacidosis. JARDIANCE is not recommended for use to improve glycemic control in ...

with mildly reduced or preserved ejection fraction (left ventricular ejection fraction [LVEF] of ≥40%). The sNDA is supported by data from the randomized, double-blind, placebo-controlled ...

Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.